What is Buruli ulcer?
Buruli Ulcer is a chronic painless necrotising ulcer with undermined edges, which can lead to debilitating skin and soft tissue infection and permanent disfigurement.
While it is known that this ulcer is caused by a bacterium, the mode of its transmission remains unclear.
However, trauma, insect bite and inhalation have been suggested as its mode of transmission.
When detected early, the majority can be cured with a combination of antibiotics.
Thus, early identification and appropriate management reduce morbidity and disability from this condition.
Causes
- Buruli Ulcer is caused by Mycobacterium ulcerans
Symptoms of Buruli Ulcer
The symptoms of Buruli Ulcer include the following:
- Painless subcutaneous nodule
- Painless swelling of the legs, arms or face
- Extensive skin ulceration
Signs
- Nodule: Painless firm lesion 1-2 cm in diameter situated in the subcutaneous tissue and attached to the skin
- Diffuse painless swelling of the legs, arms or face
- Large painless area of induration
- Extensive skin ulceration.
Investigations
- Wound swab for Acid- Fast Bacilli (AFB) smear and culture, bacterial cultures and sensitivity
- Skin biopsy for histopathology
Treatment for Buruli Ulcer
Treatment objectives
The treatment objectives of this disease condition are:
- To limit the extent of tissue destruction
- To prevent disability
- To treat both primary and secondary bacterial infection
Non-pharmacological treatment
- Complete excision of nodules, preferably with primary closure if possible
- Skin grafting of ulcers if facilities for this procedure are available
Pharmacological treatment
1st Line Treatment
Evidence Rating: [A]
Rifampicin, oral, 10 mg/kg daily for 8 weeks
And
Streptomycin, IM, 15 mg/kg daily for 8 weeks
2nd Line Treatment
Evidence Rating: [C]
Rifampicin, oral, 10 mg/kg daily for 8 weeks
And
Clarithromycin, oral, 7.5 mg/kg 12 hourly for 8 weeks
Referral Criteria
Refer patients with Buruli ulcer to health facilities with expertise for managing buruli ulcer.